JPRN-jRCT2053190103进行中（未招募）1 期
Phase I trial of ADR-002K for patients with ischemic cardiomyopathy who undergo coronary artery bypass surgery
SAWA Yoshiki0 个研究点目标入组 6 人开始时间: 2020年1月31日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 80age old（—）
- 性别
- All
入选标准
- •1) Patients who are clinically diagnosed with ischemic cardiomyopathy and receive CABG
- •2) Patients with a left ventricular ejection fraction of 40% or less by cardiac ultrasonography within 4 weeks before obtaining consent
排除标准
- •1) Patients who have a combination of cardiovascular disease such as severe organic valvular disease or aortic aneurysm determined by investigator or co-investigator to affect clinical trial procedure
- •2) Patients whose participation in a clinical trial is considered inappropriate at the discretion of the investigator or co-investigator
研究者
相似试验
已完成
1 期
Phase I trial of ADR-002K for patients with ischemic cardiomyopathy who undergo coronary artery bypass surgeryIschemic CardiomyopathyJPRN-UMIN000038809Osaka University Hospital6
招募中
2 期
A Phase 2 Study of ADR-001 in Patients with Severe Pneumonia caused by SARS-CoV-2 infectioPatients with Severe Pneumonia caused by SARS-CoV-2 infectionJPRN-jRCT2053210023Okawa Sumito20
进行中（未招募）
2 期
ADR-001-N1Compensated liver cirrhosis (Child-Pugh A)JPRN-jRCT2033210425Terai Shuji9
招募中
不适用
Phase 1b/2 trial for CKD-702 in combination with irinotecan as a third-line therapy for gastric cancer with MET or EGFR protein overexpressioNeoplasmsKCT0008025ational Cancer Center52
进行中（未招募）
不适用
A randomized clinical study of stem cells taken from fat tissue in the experimental treatment of patients with myocardial infarction (heart attack)patients with ST-elevation myocardial infarction after PCI with stentMedDRA version: 14.1Level: LLTClassification code 10028597Term: Myocardial infarction acuteSystem Organ Class: 10007541 - Cardiac disordersEUCTR2010-022153-42-DECytori Therapeutics, Inc216